Home › Cervical Cancer › District of Columbia
Cervical Cancer clinical trials in District of Columbia
5 studies for Cervical Cancer are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Georgetown University Medical Center, Washington D.C.
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05983432Pembrolizumab and Lenvatinib in Advanced Cervical Cancer
- MedStar Georgetown University Hospital, Washington D.C.
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 10, 2026 · NCT04865887A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
- Georgetown University Medical Center, Washington D.C.
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT07227168A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Washington D.C.
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07182149Video-Based Patient Navigation to Support Cervical Cancer Screening Among Black Women
- Family and Medical Counseling Service, Inc., Washington D.C.
Recruiting
Ages 21 to 65 · Women · Updated Apr 21, 2026 · NCT07011836From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.